Vitamin B2 (Riboflavin)
The flavin cofactor powering cellular energy and redox metabolism
What is Vitamin B2 (Riboflavin)?
Vitamin B2 (Riboflavin) is a vitamin used for corrects and prevents ariboflavinosis (angular stomatitis, cheilosis, glossitis, dermatitis, sore throat, normocytic anemia). NutriDex grades the human evidence as Moderate. Riboflavin (vitamin B2) is the precursor of the flavin coenzymes FMN and FAD, which are essential for oxidative energy metabolism, the electron transport chain, fatty-acid oxidation, and the metabolism of other micronutrients (folate, vitamin B6, niacin, iron). Frank deficiency (ariboflavinosis) causes angular stomatitis, cheilosis, glossitis, sore throat, normocytic anemia and dermatitis, but is rare in developed countries; correcting it resolves these signs. In non-deficient people the best-supported supplementation benefit is high-dose (400 mg/day) migraine prophylaxis in adults, where small RCTs show reduced attack frequency (NNT ~2.3 in Schoenen 1998), though pediatric results are mixed/null. Blood-pressure lowering is real but restricted to a genetic subgroup (MTHFR 677TT hypertensives); there is no evidence routine riboflavin benefits replete adults beyond these uses.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Ariboflavinosis (deficiency correction)Repletion reliably resolves deficiency signs; established by authoritative DRI bodies rather than RCTs (rare in developed countries). | Strong | ↑ benefit · large | 2 |
| Migraine prophylaxis (adults)High-dose 400 mg/day cut attack frequency (Schoenen NNT 2.3); small RCTs and reviews, well tolerated. | Moderate | ↑ benefit · moderate | 3 |
| Migraine prophylaxis (pediatric)Pediatric data are mixed: a 2025 review found benefit in most comparisons, but earlier trials were null/inconsistent. | Mixed | ↔ mixed | 2 |
| Blood pressure (MTHFR 677TT genotype)Low-dose riboflavin lowers SBP ~5-13 mmHg only in 677TT hypertensives; a genotype-targeted, not universal, effect. | Moderate | ↑ benefit · moderate | 2 |